Comments
Loading...

Pfizer

PFENYSE
Logo brought to you by Benzinga Data
$28.30
-0.22-0.77%
At close: -
$28.36
0.060.21%
After Hours: 6:58 PM EDT
15 minutes delayed
The dividend Ex-Date is in 8 days
Q3 2024 Earnings were released on Tue Oct 29th, before the market open
The most recent conference call was at 10:30 AM, 2 days ago Click to view past webcast
Consensus Rating1
Neutral
Highest Price Target1
$60.00
Lowest Price Target1
$29.00
Consensus Price Target1
$39.14

Pfizer (NYSE:PFE) Stock, Analyst Ratings, Price Targets, Forecasts

Pfizer Inc has a consensus price target of $39.14 based on the ratings of 22 analysts. The high is $60 issued by Goldman Sachs on December 13, 2022. The low is $29 issued by Morgan Stanley on May 2, 2024. The 3 most-recent analyst ratings were released by Cantor Fitzgerald, Cantor Fitzgerald, and Bernstein on October 25, 2024, October 23, 2024, and October 17, 2024, respectively. With an average price target of $40.67 between Cantor Fitzgerald, Cantor Fitzgerald, and Bernstein, there's an implied 43.50% upside for Pfizer Inc from these most-recent analyst ratings.

Analyst Trends and Forecast
3
4
Jul
2
Aug
2
Sep
3
1
Oct
Buy
Hold
Sell
Strong Sell
Analyst Rating and Forecast
12345
2.5
Sell
Strong Buy
Buy
Hold
Sell
Strong Sell

Analyst Firms Making Recommendations1

Cantor Fitzgerald
Bernstein
Daiwa Capital
Barclays
Wells Fargo

1calculated from analyst ratings

Analyst Ratings for Pfizer

Data brought to you by Benzinga APIs

FAQ

Q

What is the target price for Pfizer (PFE) stock?

A

The latest price target for Pfizer (NYSE:PFE) was reported by Cantor Fitzgerald on October 25, 2024. The analyst firm set a price target for $45.00 expecting PFE to rise to within 12 months (a possible 58.67% upside). 38 analyst firms have reported ratings in the last year.

Q

What is the most recent analyst rating for Pfizer (PFE)?

A

The latest analyst rating for Pfizer (NYSE:PFE) was provided by Cantor Fitzgerald, and Pfizer reiterated their overweight rating.

Q

When was the last upgrade for Pfizer (PFE)?

A

The last upgrade for Pfizer Inc happened on August 8, 2024 when Daiwa Capital raised their price target to $34. Daiwa Capital previously had a neutral for Pfizer Inc.

Q

When was the last downgrade for Pfizer (PFE)?

A

The last downgrade for Pfizer Inc happened on March 22, 2024 when Argus Research changed their price target from N/A to N/A for Pfizer Inc.

Q

When is the next analyst rating going to be posted or updated for Pfizer (PFE)?

A

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Pfizer, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Pfizer was filed on October 25, 2024 so you should expect the next rating to be made available sometime around October 25, 2025.

Q

Is the Analyst Rating Pfizer (PFE) correct?

A

While ratings are subjective and will change, the latest Pfizer (PFE) rating was a reiterated with a price target of $45.00 to $45.00. The current price Pfizer (PFE) is trading at is $28.36, which is out of the analyst’s predicted range.

Browse analyst ratings and price targets on all stocks.

People Also Watch